How many drugs treat Alcoholism?

Drug Landscape tracks 3 marketed treatments for Alcoholism (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/alcoholism.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Alcoholism — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Alcoholism (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Alcoholism, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Campral	ACAMPROSATE	Allergan/AbbVie	acamprosate	GABA-A receptor alpha-1/beta-3/gamma-2	2004-01-01
Revex	NALMEFENE	Hikma	Opioid Antagonist	Kappa-type opioid receptor	1995-01-01
Naltrexon	Naltrexon	Institute of Liver and Biliary Sciences, India		Neuronal acetylcholine receptor subunit alpha-7, Cytochrome P450 2D6, Delta-type opioid receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 2 drugs in Alcoholism
Allergan/AbbVie · 1 drug in Alcoholism
Hikma · 1 drug in Alcoholism
Institute of Liver and Biliary Sciences, India · 1 drug in Alcoholism

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Alcoholism:

Cite this brief

Drug Landscape (2026). Alcoholism — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/alcoholism. Accessed 2026-06-10.

Alcoholism full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing